Terapia Génica del Cáncer
TGC
Mayo Clinic
Rochester, Estados UnidosPublicaciones en colaboración con investigadores/as de Mayo Clinic (3)
2021
-
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
The Lancet Diabetes and Endocrinology, Vol. 9, Núm. 8, pp. 491-501
2010
-
Immunology and gene therapy: Shoulder to shoulder into the fray
Molecular Therapy
2002
-
Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen
Clinical Cancer Research, Vol. 8, Núm. 10, pp. 3219-3225